Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTDS in Opioid-Naïve Subjects with Moderate to Severe Chronic OA Knee Pain
NCT00531427Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Sep 2007
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Buprenorphine Transdermal System with Placebo (2 arms). Primary endpoint: Average Pain Over the Last 24 Hours Score of the Study Knee at Week 12. Started Sep 2007; status: completed.
02
Drugs
buprenorphine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00531427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531427.